Glenmark Pharma Introduces Lacosamide Oral Solution, 10 mg/mL to US Consumers
Glenmark Pharmaceuticals Inc., USA has unveiled the lacosamide oral solution at a concentration of 10 mg/mL. This product matches the bioequivalence and therapeutic effects of the reference drug, Vimpat Oral Solution at the same strength, originally produced by UCB, Inc. […]
Glenmark Pharma Introduces Lacosamide Oral Solution, 10 mg/mL to US Consumers Read More »